Koen Dreijerink
@koendreijerink.bsky.social
Endocrinology, endocrine oncology, gender-affirming hormone therapy, functional epigenetics
Reposted by Koen Dreijerink
link.springer.com/article/10.1... Good to see more molecular data in functioning NET, in this case showing added value of staining ATRX/DAXX in insulinoma and possibly the rare functioning syndromes. Anybody using this in routine practice for panNET? @koendreijerink.bsky.social #medsky #NETs
February 24, 2025 at 9:25 PM
link.springer.com/article/10.1... Good to see more molecular data in functioning NET, in this case showing added value of staining ATRX/DAXX in insulinoma and possibly the rare functioning syndromes. Anybody using this in routine practice for panNET? @koendreijerink.bsky.social #medsky #NETs
Great thyroid cancer guideline session at the Dutch Endocrine Meeting 2025 with @wzandee.bsky.social! DEM 2025, NVE
February 7, 2025 at 3:39 PM
Great thyroid cancer guideline session at the Dutch Endocrine Meeting 2025 with @wzandee.bsky.social! DEM 2025, NVE